The Price of a Cure? How Big Pharma Can Help Poverty-stricken Populations
On: 06/17/2010 Views: 14
How much is a cure for an illness that afflicts the poor really worth? That question is the cornerstone of a plan by Thomas Pogge, a Yale University professor of philosophy and international affairs, to address disconnects in pharmaceutical innovation that leave millions in the developing world suffering from neglected diseases. In a recent presentation at Wharton, Pogge explained how his Health Impact Fund would employ the true value of a cure to encourage drug makers to come up with medicines that would help poverty-stricken populations around the world.